Position in PRGO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$11,043,546
+$1,321,669 QoQ
Shares Held
1,062,902
+17.4% QoQ
Ownership
0.766%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. PRGO ranks #17 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in PRGO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,043,546 | 1,062,902 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $9,721,877 | 905,203 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $13,178,226 | 946,712 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $19,516,733 | 876,369 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $25,936,884 | 970,692 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $27,589,700 | 983,941 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $26,434,297 | 1,028,172 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $25,522,230 | 973,017 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $27,879,668 | 1,085,657 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $34,650,534 | 1,076,438 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $37,167,412 | 1,154,985 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $37,557,827 | 1,175,519 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $41,099,628 | 1,210,593 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $44,162,028 | 1,231,169 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $43,024,677 | 1,262,091 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,927,022 | 1,315,957 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $53,325,568 | 1,314,409 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $50,130,240 | 1,304,456 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $51,332,630 | 1,319,605 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $61,436,181 | 1,298,039 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $48,703,699 | 1,062,240 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $38,722,176 | 956,812 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $45,315,307 | 1,013,312 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $47,805,252 | 1,041,282 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $54,630,908 | 988,437 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $45,701,749 | 950,338 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||